Fidelity Investments
MTCR

Fidelity Investments’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Fidelity Investments’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-312,500
Closed -$1.19M – 5263
2021
Q2 		$1.19M Hold
312,500
– – ﹤0.01% 2634
2021
Q1 		$1.94M Sell
312,500
-187,500
-38% -$1.66M ﹤0.01% 2477
2020
Q4 		$3.93M Hold
500,000
– – ﹤0.01% 2236
2020
Q3 		$5.08M Buy
+500,000
New +$5.12M ﹤0.01% 2070

Other funds holding MTCR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments's MTCR Position: Q3 2021 in Review

Fidelity Investments sold out of Metacrine, Inc. Common Stock (MTCR) in Q3 2021, closing a stake of 312,500 shares — an estimated $1.19M sold.

Fidelity Investments first reported a position in MTCR in Q3 2020 and held it in 4 quarters. The position peaked at $5.08M in Q3 2020. 35 funds tracked by Wall St. Rank hold MTCR as of Q3 2021.

  • Fidelity Investments reported no remaining Metacrine, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Fidelity Investments sold 312,500 Metacrine, Inc. Common Stock shares in Q3 2021, an estimated $1.19M.
  • Fidelity Investments first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Fidelity Investments's Metacrine, Inc. Common Stock position peaked at $5.08M in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q3 2021.

Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.